Q96KG7 (MEG10_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 89.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Multiple epidermal growth factor-like domains protein 10 Short name=Multiple EGF-like domains protein 10 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1140 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Membrane receptor involved in phagocytosis by macrophages of apoptotic cells. Cooperates with ABCA1 within the process of engulfment. Promotes the formation of large intracellular vacuoles and may be responsible for the uptake of amyloid-beta peptides. May also function in the mosaic spacing of specific neuron subtypes in the retina through homotypic retinal neuron repulsion. Mosaics provide a mechanism to distribute each cell type evenly across the retina, ensuring that all parts of the visual field have access to a full set of processing elements. May play role in cell adhesion and motility. Is also an essential factor in the regulation of myogenesis. Controls the balance between skeletal muscle satellite cells proliferation and differentiation problably through regulation of the notch signaling pathway. Ref.6 Ref.7 Ref.8 Ref.9 |
| Subunit structure | Homopolymer Probable. Interacts with GULP1 and ABCA1. Interacts with AP2M1. Does not interact with MEGF11. Ref.5 Ref.6 Ref.7 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Basolateral cell membrane; Single-pass type I membrane protein. Cell projection › phagocytic cup. Note: Enriched at the sites of contact with apoptotic thymocyte cells By similarity. Forms an irregular, mosaic-like adhesion pattern in region of the cell surface that becomes firmely fixed to the substrate. Expressed at the cell surface in clusters around cell corpses during engulfment. During the engulfment of apoptotic thymocytes, recruited at the bottom of the forming phagocytic cup. Colocalizes with ABCA1 in absence of any phagocytic challenge. Does not localize within lamellipodia. Does not localize with MEGF11. Ref.5 Ref.6 |
| Domain | The EMI and EGF-like domains work in concert to promote self-assembly. |
| Post-translational modification | Phosphorylated on tyrosine residues. Ref.7 Ubiquitinated; mono- and polyubiquitinated forms are detected. Ref.7 |
| Involvement in disease | Myopathy, early-onset, areflexia, respiratory distress, and dysphagia (EMARDD) [MIM:614399]: An autosomal recessive congenital myopathy characterized by onset at birth, or early in infancy, of respiratory distress caused by diaphragmatic weakness. Additional features are dysphagia resulting in poor feeding, failure to thrive, poor head control, facial weakness, cleft palate, contractures and scoliosis. Affected individuals become ventilator-dependent, and most require feeding by gastrostomy. The disorder results in severe muscle weakness and most patients never achieve walking. Death from respiratory failure in childhood occurs in about half of patients. Muscle biopsies from affected individuals show myopathic changes, replacement of myofibers with fatty tissue, small and incompletely fused muscle fibers, and variation in fiber size. Short regions of sarcomeric disorganization with few or no mitochondria (minicores) have been observed in some cases. |
| Sequence similarities | Belongs to the MEGF family. Contains 15 EGF-like domains. Contains 1 EMI domain. |
| Sequence caution | The sequence BAB47409.2 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96KG7-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96KG7-2) The sequence of this isoform differs from the canonical sequence as follows: 566-567: VH → LF 568-1140: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Potential | ||||||||
| Chain | 26 – 1140 | 1115 | Multiple epidermal growth factor-like domains protein 10 | PRO_0000309732 | |||||||
Regions | |||||||||||
| Topological domain | 26 – 857 | 832 | Extracellular Potential | ||||||||
| Transmembrane | 858 – 878 | 21 | Helical; Potential | ||||||||
| Topological domain | 879 – 1140 | 262 | Cytoplasmic Potential | ||||||||
| Domain | 30 – 107 | 78 | EMI | ||||||||
| Domain | 106 – 136 | 31 | EGF-like 1 | ||||||||
| Domain | 144 – 179 | 36 | EGF-like 2 | ||||||||
| Domain | 187 – 222 | 36 | EGF-like 3 | ||||||||
| Domain | 230 – 265 | 36 | EGF-like 4 | ||||||||
| Domain | 278 – 308 | 31 | EGF-like 5 | ||||||||
| Domain | 316 – 351 | 36 | EGF-like 6 | ||||||||
| Domain | 405 – 440 | 36 | EGF-like 7 | ||||||||
| Domain | 453 – 483 | 31 | EGF-like 8 | ||||||||
| Domain | 491 – 526 | 36 | EGF-like 9 | ||||||||
| Domain | 539 – 569 | 31 | EGF-like 10 | ||||||||
| Domain | 577 – 612 | 36 | EGF-like 11 | ||||||||
| Domain | 665 – 700 | 36 | EGF-like 12 | ||||||||
| Domain | 713 – 743 | 31 | EGF-like 13 | ||||||||
| Domain | 751 – 786 | 36 | EGF-like 14 | ||||||||
| Domain | 799 – 829 | 31 | EGF-like 15 | ||||||||
| Region | 1 – 857 | 857 | Necessary for interaction with AP2M1, self-assembly and formation of the irregular, mosaic-like adhesion pattern | ||||||||
| Region | 945 – 1140 | 196 | Necessary for formation of large intracellular vacuoles | ||||||||
| Compositional bias | 1119 – 1139 | 21 | Ser-rich | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 134 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 496 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Disulfide bond | 34 ↔ 95 | Potential | |||||||||
| Disulfide bond | 60 ↔ 69 | Potential | |||||||||
| Disulfide bond | 94 ↔ 105 | Potential | |||||||||
| Disulfide bond | 109 ↔ 118 | By similarity | |||||||||
| Disulfide bond | 113 ↔ 124 | By similarity | |||||||||
| Disulfide bond | 126 ↔ 135 | By similarity | |||||||||
| Disulfide bond | 148 ↔ 160 | By similarity | |||||||||
| Disulfide bond | 154 ↔ 167 | By similarity | |||||||||
| Disulfide bond | 169 ↔ 178 | By similarity | |||||||||
| Disulfide bond | 191 ↔ 203 | By similarity | |||||||||
| Disulfide bond | 197 ↔ 210 | By similarity | |||||||||
| Disulfide bond | 212 ↔ 221 | By similarity | |||||||||
| Disulfide bond | 234 ↔ 246 | By similarity | |||||||||
| Disulfide bond | 240 ↔ 253 | By similarity | |||||||||
| Disulfide bond | 255 ↔ 264 | By similarity | |||||||||
| Disulfide bond | 281 ↔ 289 | By similarity | |||||||||
| Disulfide bond | 283 ↔ 296 | By similarity | |||||||||
| Disulfide bond | 298 ↔ 307 | By similarity | |||||||||
| Disulfide bond | 320 ↔ 332 | By similarity | |||||||||
| Disulfide bond | 326 ↔ 339 | By similarity | |||||||||
| Disulfide bond | 341 ↔ 350 | By similarity | |||||||||
| Disulfide bond | 409 ↔ 421 | By similarity | |||||||||
| Disulfide bond | 415 ↔ 428 | By similarity | |||||||||
| Disulfide bond | 430 ↔ 439 | By similarity | |||||||||
| Disulfide bond | 456 ↔ 464 | By similarity | |||||||||
| Disulfide bond | 458 ↔ 471 | By similarity | |||||||||
| Disulfide bond | 473 ↔ 482 | By similarity | |||||||||
| Disulfide bond | 495 ↔ 507 | By similarity | |||||||||
| Disulfide bond | 501 ↔ 514 | By similarity | |||||||||
| Disulfide bond | 516 ↔ 525 | By similarity | |||||||||
| Disulfide bond | 542 ↔ 550 | By similarity | |||||||||
| Disulfide bond | 544 ↔ 557 | By similarity | |||||||||
| Disulfide bond | 559 ↔ 568 | By similarity | |||||||||
| Disulfide bond | 581 ↔ 593 | By similarity | |||||||||
| Disulfide bond | 587 ↔ 600 | By similarity | |||||||||
| Disulfide bond | 602 ↔ 611 | By similarity | |||||||||
| Disulfide bond | 669 ↔ 681 | By similarity | |||||||||
| Disulfide bond | 675 ↔ 688 | By similarity | |||||||||
| Disulfide bond | 690 ↔ 699 | By similarity | |||||||||
| Disulfide bond | 716 ↔ 724 | By similarity | |||||||||
| Disulfide bond | 718 ↔ 731 | By similarity | |||||||||
| Disulfide bond | 733 ↔ 742 | By similarity | |||||||||
| Disulfide bond | 755 ↔ 767 | By similarity | |||||||||
| Disulfide bond | 761 ↔ 774 | By similarity | |||||||||
| Disulfide bond | 776 ↔ 785 | By similarity | |||||||||
| Disulfide bond | 802 ↔ 810 | By similarity | |||||||||
| Disulfide bond | 804 ↔ 817 | By similarity | |||||||||
| Disulfide bond | 819 ↔ 828 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 566 – 567 | 2 | VH → LF in isoform 2. | VSP_029244 | |||||||
| Alternative sequence | 568 – 1140 | 573 | Missing in isoform 2. | VSP_029245 | |||||||
| Natural variant | 71 | 1 | R → W in a patient with EMARDD; unknown pathological significance. Ref.10 | VAR_067469 | |||||||
| Natural variant | 206 | 1 | V → I. Corresponds to variant rs3812054 [ dbSNP | Ensembl ]. | VAR_036988 | |||||||
| Natural variant | 326 | 1 | C → R in EMARDD. Ref.10 | VAR_067470 | |||||||
| Natural variant | 774 | 1 | C → R in EMARDD. Ref.9 Ref.10 | VAR_067471 | |||||||
| Natural variant | 897 | 1 | P → L. Corresponds to variant rs13183625 [ dbSNP | Ensembl ]. | VAR_046377 | |||||||
| Natural variant | 1072 | 1 | R → K. Corresponds to variant rs17164935 [ dbSNP | Ensembl ]. | VAR_036989 | |||||||
Experimental info | |||||||||||
| Mutagenesis | 927 | 1 | N → A: Does not interact with GULP1; when associated with A-930. Ref.5 | ||||||||
| Mutagenesis | 930 | 1 | Y → A: Does not interact with GULP1; when associated with A-927. Ref.5 | ||||||||
| Sequence conflict | 543 | 1 | D → G in CAH18275. Ref.2 | ||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Nakayama M., Nakajima D., Kikuno R., Ohara O. DNA Res. 8:85-95(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain. |
| [2] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Retina. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Muscle. |
| [5] | "Cooperation between engulfment receptors: the case of ABCA1 and MEGF10." Hamon Y., Trompier D., Ma Z., Venegas V., Pophillat M., Mignotte V., Zhou Z., Chimini G. PLoS ONE 1:E120-E120(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GULP1 AND ABCA1, MUTAGENESIS OF ASN-927 AND TYR-930, SUBCELLULAR LOCATION. |
| [6] | "The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern." Suzuki E., Nakayama M. Exp. Cell Res. 313:2451-2464(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [7] | "MEGF10 is a mammalian ortholog of CED-1 that interacts with clathrin assembly protein complex 2 medium chain and induces large vacuole formation." Suzuki E., Nakayama M. Exp. Cell Res. 313:3729-3742(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MASS SPECTROMETRY, INTERACTION WITH AP2M1 AND GULP1, PHOSPHORYLATION, UBIQUITINATION. |
| [8] | "MEGF10 functions as a receptor for the uptake of amyloid-beta." Singh T.D., Park S.Y., Bae J.S., Yun Y., Bae Y.C., Park R.W., Kim I.S. FEBS Lett. 584:3936-3942(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN ENDOCYTOSIS. |
| [9] | "Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)." Logan C.V., Lucke B., Pottinger C., Abdelhamed Z.A., Parry D.A., Szymanska K., Diggle C.P., Riesen A., Morgan J.E., Markham G., Ellis I., Manzur A.Y., Markham A.F., Shires M., Helliwell T., Scoto M., Hubner C., Bonthron D.T. Johnson C.A.Nat. Genet. 43:1189-1192(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN MYOGENESIS, VARIANT EMARDD ARG-774. |
| [10] | "Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores." Boyden S.E., Mahoney L.J., Kawahara G., Myers J.A., Mitsuhashi S., Estrella E.A., Duncan A.R., Dey F., Dechene E.T., Blasko-Goehringer J.M., Bonnemann C.G., Darras B.T., Mendell J.R., Lidov H.G., Nishino I., Beggs A.H., Kunkel L.M., Kang P.B. Neurogenetics 13:115-124(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS EMARDD ARG-326 AND ARG-774, VARIANT TRP-71. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB058676 mRNA. Translation: BAB47409.2. Different initiation. CR749437 mRNA. Translation: CAH18275.1. CH471062 Genomic DNA. Translation: EAW62406.1. BC020198 mRNA. Translation: AAH20198.1. BC152478 mRNA. Translation: AAI52479.1. |
| IPI | IPI00064607. IPI00873983. |
| RefSeq | NP_001243474.1. NM_001256545.1. NP_115822.1. NM_032446.2. |
| UniGene | Hs.438709. |
3D structure databases | |
| HSSP | HSSP built from PDB template 1EGF based on UniProtKB P01132. |
| ProteinModelPortal | Q96KG7. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q96KG7. 24 interactions. |
| STRING | 9606.ENSP00000274473. |
PTM databases | |
| PhosphoSite | Q96KG7. |
Polymorphism databases | |
| DMDM | 74716908. |
Proteomic databases | |
| PaxDb | Q96KG7. |
| PRIDE | Q96KG7. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000274473; ENSP00000274473; ENSG00000145794. ENST00000418761; ENSP00000416284; ENSG00000145794. ENST00000503335; ENSP00000423354; ENSG00000145794. ENST00000508365; ENSP00000423195; ENSG00000145794. |
| GeneID | 84466. |
| KEGG | hsa:84466. |
| UCSC | uc003kuh.4. human. uc010jdc.1. human. |
Organism-specific databases | |
| CTD | 84466. |
| GeneCards | GC05P126654. |
| HGNC | HGNC:29634. MEGF10. |
| HPA | HPA026876. |
| MIM | 612453. gene. 614399. phenotype. |
| neXtProt | NX_Q96KG7. |
| Orphanet | 98920. Spinal muscular atrophy with respiratory distress. |
| PharmGKB | PA144596410. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG12793. |
| HOGENOM | HOG000294130. |
| HOVERGEN | HBG108333. |
| InParanoid | Q96KG7. |
| OMA | FGCNLTC. |
| PhylomeDB | Q96KG7. |
Gene expression databases | |
| Bgee | Q96KG7. |
| CleanEx | HS_MEGF10. |
| Genevestigator | Q96KG7. |
Family and domain databases | |
| InterPro | IPR000742. EG-like_dom. IPR013032. EGF-like_CS. IPR002049. EGF_laminin. IPR011489. EMI_domain. [Graphical view] |
| Pfam | PF12661. hEGF. 3 hits. PF00053. Laminin_EGF. 6 hits. [Graphical view] |
| SMART | SM00181. EGF. 11 hits. SM00180. EGF_Lam. 6 hits. [Graphical view] |
| PROSITE | PS00022. EGF_1. 17 hits. PS01186. EGF_2. 17 hits. PS50026. EGF_3. 15 hits. PS51041. EMI. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 84466. |
| NextBio | 74274. |
| SOURCE | Search... |
Entry information
| Entry name | MEG10_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96KG7 Secondary accession number(s): Q68DE5, Q8WUL3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
